Glutamine alpha-ketogutarate

Evidence: Limited
Amino-acidAmino acid derivative

Useful mainly for clinical-nutrition contexts (surgical/critically ill) under medical supervision.

Quick decision guide

May help most

clinical-nutrition contexts (surgical/critically ill) under medical supervision

Common dosing range

varies; clinical studies use gram-level doses, often intravenous

When to expect effects

Days in clinical settings

Watch out for

Studied mainly in hospital settings; benefit in healthy people is unproven

What is it

Glutamine alpha-ketoglutarate (G-AKG) is a salt pairing the amino acid glutamine with alpha-ketoglutarate, a Krebs-cycle intermediate. It is used in clinical nutrition to supply glutamine and supply carbon/nitrogen substrate, mainly studied in surgical, critically ill, or parenterally fed patients. Consumer use is marketed for muscle and recovery, but evidence in healthy people is sparse.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

it is part of a clinically supervised nutrition protocol
you have a condition with high glutamine demand managed by a clinician

Probably skip if

you are a healthy person seeking muscle gains
you expect performance benefits proven in trials
you could meet needs with ordinary dietary protein

Evidence at a glance

GoalEvidenceEffectBest fitTime
nitrogen balance in surgical or critically ill patientsLimitedImproved nitrogen balance in some studiespost-surgical or critically ill patients receiving nutrition supportDays

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

nitrogen balance in surgical or critically ill patients

Biomarker support
Limited

Small clinical-nutrition studies, often using parenteral glutamine alpha-ketoglutarate, report improved nitrogen balance and glutamine status in surgical or critically ill patients. Evidence is limited, heterogeneous, and centered on metabolic biomarkers rather than clear clinical outcomes, and does not extend to healthy users.

Effect size: Improved nitrogen balance in some studies
Time to effect: Days
Best fit: post-surgical or critically ill patients receiving nutrition support
Less likely: healthy adults seeking performance or muscle benefit

Bottom line: Some biomarker support in clinical nutrition settings, with little relevance to healthy consumers.

How to take it

Typical dose
as directed clinically; consumer dosing is not well established
Timing
per protocol
With food
either
How long to try
short-term in clinical use

What to track

  • clinical recovery markers if used medically
  • GI tolerance
  • guidance from a supervising clinician

Safety

Common side effects

GI upset

Who should avoid it

  • people with significant kidney or liver impairment unless supervised

Pregnancy & breastfeeding

No adequate safety data; avoid outside medical supervision.

Choosing a product

Look for

  • states glutamine and alpha-ketoglutarate content
  • clear sourcing and purity testing

Be skeptical of

  • muscle-building or anti-aging guarantees
  • extrapolating hospital findings to healthy users
  • longevity claims borrowed from alpha-ketoglutarate hype

References by claim

nitrogen balance in surgical or critically ill patients

  • Blomqvist et al., 1995PubMed (1995) link
  • Parmana et al., 2022PMC (2022) link

Track Glutamine alpha-ketogutarate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.